Literature DB >> 22162743

Risk-specific optimal cancer screening schedules: an application to breast cancer early detection.

Charlotte Hsieh Ahern1, Yi Cheng, Yu Shen.   

Abstract

The optimal schedules for breast cancer screening in terms of examination frequency and ages at examination are of practical interest. A decision-theoretic approach is explored to search for optimal cancer screening programs which should achieve maximum survival benefit while balancing the associated cost to the health care system. We propose a class of utility functions that account for costs associated with screening examinations and value of survival benefit under a non-stable disease model. We consider two different optimization criteria: optimize the number of screening examinations with equal screening intervals between exams but without a pre-fixed total cost; and optimize the ages at which screening should be given for a fixed total cost. We show that an optimal solution exists under each of the two frameworks. The proposed methods may consider women at different levels of risk for breast cancer so that the optimal screening strategies will be tailored according to a woman's risk of developing the disease. Results of a numerical study are presented and the proposed models are illustrated with various data inputs. We also use the data inputs from the Health Insurance Plan of New York (HIP) and Canadian National Breast Screening Study (CNBSS) to illustrate the proposed models and to compare the utility values between the optimal schedules and the actual schedules in the HIP and CNBSS trials. Here, the utility is defined as the difference in cure rates between cases found at screening examinations and cases found between screening examinations while accounting for the cost of examinations, under a given screening schedule.

Entities:  

Year:  2011        PMID: 22162743      PMCID: PMC3230228          DOI: 10.1007/s12561-011-9032-7

Source DB:  PubMed          Journal:  Stat Biosci        ISSN: 1867-1764


  11 in total

1.  Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations.

Authors:  Y Shen; M Zelen
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

2.  A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.

Authors:  Yu Shen; Giovanni Parmigiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-02       Impact factor: 4.254

3.  Retrospective cost-effectiveness analysis of screening mammography.

Authors:  Natasha K Stout; Marjorie A Rosenberg; Amy Trentham-Dietz; Maureen A Smith; Stephen M Robinson; Dennis G Fryback
Journal:  J Natl Cancer Inst       Date:  2006-06-07       Impact factor: 13.506

Review 4.  Use of modeling to evaluate the cost-effectiveness of cancer screening programs.

Authors:  Amy B Knudsen; Pamela M McMahon; G Scott Gazelle
Journal:  J Clin Oncol       Date:  2007-01-10       Impact factor: 44.544

5.  On the optimal policies of cancer screening.

Authors:  A D Tsodikov
Journal:  Math Biosci       Date:  1991-11       Impact factor: 2.144

6.  A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

Authors:  P R Rosen; S Groshen; P E Saigo; D W Kinne; S Hellman
Journal:  J Clin Oncol       Date:  1989-03       Impact factor: 44.544

7.  Simplified models of screening for chronic disease: estimation procedures from mass screening programmes.

Authors:  N E Day; S D Walter
Journal:  Biometrics       Date:  1984-03       Impact factor: 2.571

Review 8.  Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups.

Authors:  Rob Boer; Sylvia Plevritis; Lauren Clarke
Journal:  Stat Methods Med Res       Date:  2004-12       Impact factor: 3.021

9.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

10.  Benefits and costs of interventions to improve breast cancer outcomes in African American women.

Authors:  Jeanne S Mandelblatt; Clyde B Schechter; K Robin Yabroff; William Lawrence; James Dignam; Peter Muennig; Yoko Chavez; Jennifer Cullen; Marianne Fahs
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.